The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over 2 seasons.

RSV, or respiratory syncytial virus, is a common illness that can cause serious breathing problems in infants, young children ...

Mandy Moore recalls when her sons were both diagnosed with RSV in 2023, and how the scary health ordeal made her feel in an ...

A large, real-world randomized trial in Denmark found that the RSVpreF vaccine reduced RSV-related hospitalizations in adults ...

In Florida, many pharmacists, doctors, and patients find themselves confused about who has access to vaccines for COVID-19, ...

Comorbidities are seen less often in severe RSV infection in infants younger than 3 months compared with older children.

A multi-institutional collaboration led by the Center for Translational Cardiology and Pragmatic Randomized Trials at Copenhagen University Hospital-Herlev and Gentofte, University of Copenhagen, ...

“Over the age of 60, your immune system becomes a little less active,” he explains, meaning it can be harder to fend off ...

Manitoba is expanding its immunization program to help protect infants who are born during respiratory syncytial virus season ...

Nova Scotia is spending $6.9 million to launch a new program to vaccinate or protect infants and some seniors against ...

GSK announced today that Arexvy (respiratory syncytial virus vaccine – recombinant, AS01E adjuvanted) will be offered through ...

With the approach of fall likely bringing the usual uptick in respiratory illness, the provincial government is boosting its range of protections against RSV, with free vaccines available for more ...